Compare · AJAX vs IBB
AJAX vs IBB
Side-by-side comparison of Ajax I (AJAX) and iShares Nasdaq Biotechnology Index Fund (IBB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AJAX and IBB operate in n/a (n/a), so they compete in similar markets.
- AJAX carries a market cap of $753.1M.
Ajax I
Ajax I does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Ajax I was founded in 2020 and is based in New York, New York.
iShares Nasdaq Biotechnology Index Fund
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest AJAX
- SEC Form 25-NSE filed by Ajax I
- Cazoo to Begin Trading on NYSE Today Under the Symbol "CZOO"
- SEC Form SC 13G/A filed by Ajax I (Amendment)
- Ajax I filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events
- AJAX I Shareholders Approve Proposed Business Combination with Cazoo
- SEC Form 8-K filed by Ajax I
- SEC Form SC 13G filed by Ajax I
- SEC Form 10-Q filed by Ajax I
- Ajax I filed SEC Form 8-K: Other Events
- SEC Form DEFA14A filed by Ajax I
Latest IBB
- Altimmune Added to Nasdaq Biotechnology Index
- Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
- Stocks Stalls As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
- April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
- AI, Biotech, Energy Sectors Expect M&A Revival For 2024
- Live On CNBC, Jason Snipe's Contrarian Idea: Biotech; Names IShares Biotechnology ETF
- US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday?
- Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?
- Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
- Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday?